The SPDR S&P Biotech ETF (XBI) provides exposure to one of the broadest portfolios among US biotech ETFs. The fund equal-weights its portfolio, which in turn emphasizes small- and micro-caps and greatly reduces single-name risk. Thus, the weighted-average market cap is much smaller than some competitors. Unlike other funds in this segment, XBI is a pure biotech play, with relatively small pharma overlap. For XBI Options Trading, they trade with only Friday expirations priced in increments of $0.50. and are a very popular, low priced play which can often provide weekly gains of over 5,000%.
2016 – 2018 Ranges: (44.16 – 69.21) (58.66 – 88.98) (64.38 – 101.55)
1-Month Range: 81.45 – 89.30
Weekly Chart
Daily Chart
5 Day Chart
Pivot Points
(updated weekly after Friday’s close)
| Support/Resistance Levels | Price | Key Turning Points |
|---|---|---|
| 14 Day RSI at 80% | 105.97 | |
| 52-Week High | 101.06 | |
| 14 Day RSI at 70% | 94.67 | |
| 13-Week High | 90.41 | |
| 1-Month High | 89.30 | |
| Pivot Point 2nd Level Resistance | 87.01 | |
| Pivot Point 1st Resistance Point | 86.41 | |
| High | 86.33 | High |
| Previous Close | 85.94 | Previous Close |
| Last | 85.82 | Last |
| 85.74 | Pivot Point | |
| 85.62 | 14 Day RSI at 50% | |
| Pivot Point 1st Support Point | 85.14 | |
| Low | 85.06 | Low |
| Pivot Point 2nd Support Point | 84.47 | |
| 1-Month Low | 81.45 | |
| 13-Week Low | 79.31 | |
| 14 Day RSI at 30% | 76.32 | |
| 14 Day RSI at 20% | 64.69 | |
| 52-Week Low | 64.38 |
